Vir is holding off on advancing the combination therapy to Phase III trials until it secures a development partner.

Discover a study that raises important concerns about the long-term mental health of individuals with resolved HBV infection.

New findings to be presented at the 2025 European Association for the Study of the Liver (EASL) Congress continue to demonstrate the effectiveness of Livdelzi (seladelpar) in reducing pruritus in ...

Scientists from the College of Medicine of National Taiwan University and National Taiwan University Children's Hospital identified that the Hepatitis B e antigen (HBeAg) seroconversion in ...

The three most common viruses that cause hepatitis are hepatitis A, hepatitis B and hepatitis C, and depending on the type can be spread through close contact, consuming contaminated food ...

or factors independent of hepatitis B. Whether HBeAg-negative hepatitis caused by mutations in the core promoter and/or precore region occur more frequently in IFN- or lamivudine-treated ...

Background: Hepatitis B virus (HBV) infection poses a significant public health ... The PMTCT strategy included HBsAg-screening for pregnant women. Newborns of HBsAg-positive mothers receive an ...

The complement system is a key component of the innate immune system. In antiacetylcholine receptor (AChR) antibody-positive (Ab+) generalized myasthenia gravis (MG), complement activation has long ...

With this approval, this Columvi combination is the first bispecific antibody regimen available for people with DLBCL in Europe whose cancer has returned or for those who did not respond to ...